Acute Myeloid Leukemia (AML) has a peak incidence in elderly patients with the median age of onset being 68 years.
Owing to the advanced age and multiple comorbidities, such patients are not candidates for the standard chemotherapeutic protocols.
Here we discuss the treatment strategies employed for newly diagnosed elderly patients with AML at our institution and their associated outcomes.
